Medicare Drug Benefit - A Rising Tide Raises All Prices?
Tom Curb, R.Ph., Consultant
(It would be redundant for me to again "beat up" on the Funded Medicare Drug Benefit by criticizing its poor design, its complexity, bungled implementation, and deceptions. These are exposed daily in great detail by respected national and local media. So, this commentary focuses on only one aspect its creating increased Rx costs for consumers and taxpayers.)
First I need to make it clear that I did then and still do support Medicares 1960s medical benefit. Anyone who has seen the elderly sick and dying from lack of medical care would, too. But there are major differences between this "funded" drug program and the medical benefit: (1) The medical benefit is universal, and (2) providers did not design it in fact, most feared its revenue impact and opposed its implementation. I recall only one "country" doctor who embraced it, exclaiming, "Now Im going to be paid for services that I have been giving away for years."
Because medical providers could not charge other payers less than they charged Medicare, for two decades - until price controls were imposed in the 1980s - lobbyists manipulated the program, and healthcare costs increased for everyone. I vividly remember when our hospitals inpatient charge for a 65 cent bottle of aspirin increased overnight to $100 simply because Medicare would pay that much so everyone else had to pay at least that amount, too. Because of Medicares "cost-based reimbursement" other healthcare services also inflated exponentially.
Earlier, I predicted that Medicares funded drug "benefit" would follow the inflationary pattern of the initial medical benefit and it is doing so "in spades". Even greater excesses were projected since - unlike the medical benefit - Rx providers, Medicare-PBMs, insurers, and the multinational drug cartel were allowed to design the program for their own benefit not for that of recipients.
Case in Point: For months my "Medicare HMO" charged a cash price of $20.30 for 100 tablets of my thyroid supplement. Yes, I felt that this was a little high, since more than 15 years ago as an agent for that same institution, I got them the same brand, same manufacturer for about $3 and the generic for less than a dollar.* Obviously I was pleased when last weeks refill receipt showed my "copay" at only $16 finally a price decrease! Then I took another look at the receipt.
In an area where usually was noted, "TP Paid: $00", it now showed, "TP Paid: $14.48". I asked its meaning, and the reply was, "The $14.48 is what your insurer paid." I said I had no insurer. When asked if I was enrolled in Medicare, I said, "Yes". "Did you enroll in Plan D?" I said, "No". "Well, we enrolled you automatically." "Then you can now disenroll me automatically."
What this reveals is that although the manufacturer has had no price
increase in over three years, overnight this provider went up more than 50% on that drug
simply because the governments program will allow it. By the way, my final question
was, "How much will the cash price be in the future?" The reply was, "$30.48".
So
since Medicare will allow more cost, that higher total price applicable to Plan D
enrollees will now be charged to cash customers as well.
I now find that I can get my drugs equivalent, market leading, brand-name, $60-plus (in the US) competitor from our Canadian friends for under $20. Guess where Ill get my next refill.
(*This drug has been in the U.S. for about 40 years and had lost patent protection. Despite multiple studies showing the clinical equivalence of the various products, competitive manufacturers still argued their drugs merits. In its infinite wisdom, the U.S. government solved that "problem" at consumers expense, of course. They let all the companies submit new drug applications "NDAs", and a new form of patent protection was allowed. Today the wholesale cost for some "sole source" brands exceeds $63 per 100. )